Mohammed Milhem, Professor of Internal Medicine, Division of Hematology and Oncology; Sarcoma and Melanoma Specialist at University of Iowa Health Care, shared on LinkedIn:
“Iowa played a substantial role in helping this agent get FDA approval as the first drug for the treatment of metastatic uveal melanoma.”
You can also read:
